CTRI/2017/12/010795Not yet recruiting未知
â??Comparative 6 month clinical study of Modified Coronally Advanced Flap(MCAF) and Minimally Invasive Coronally Advanced Flap(MICAF) for the treatment of multiple adjacent gingival recession defectsâ??
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Patients who agree to participate in the study by signing the informed consent.
- •2. Presence of bilateral maxillary gingival recessions >=2mm classified as Millers class 1 in the esthetic zone of the oral cavity with gingival biotype >=1mm.
- •3. Difference in depth of the gingival recessions between the right & left side <=1mm & difference in clinical attachment <=2mm.
- •4. Probing depth less than 3mm & full mouth plaque score <20%, full mouth gingival index score <20%.
- •5. Properly aligned teeth in the arch without any malposition
Exclusion Criteria
- •1. Patients with systemically compromised health & contraindicated for periodontal surgery.
- •2. Periodontal surgical treatment during the previous 24 months on the involved sites.
- •3. Current pregnancy or lactation.
- •4. Patient with smoking habit.
- •5. Patient with unjustified absence for scheduled visits, continued traumatic tooth brushing,faulty plaque control measures.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.EUCTR2007-001975-12-BEPIERRE FABRE MEDICAMENT - IDPF200
Active, not recruiting
Not Applicable
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Mild Cognitive ImpairmentMedDRA version: 9.1Level: LLTClassification code 10009846Term: Cognitive impairmentEUCTR2007-001975-12-FIPIERRE FABRE MEDICAMENT - IDPF210
Active, not recruiting
Phase 1
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Mild Cognitive ImpairmentMedDRA version: 9.1Level: LLTClassification code 10009846Term: Cognitive impairmentEUCTR2007-001975-12-FRPIERRE FABRE MEDICAMENT - IDPF200
Active, not recruiting
Phase 1
Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson’s disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Fatigue symptoms in Parkinson's disease.MedDRA version: 9.1 Level: LLT Classification code 10013113 Term: Disease Parkinson'sEUCTR2007-002195-34-FRPIERRE FABRE MEDICAMENT120
Active, not recruiting
Not Applicable
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.EUCTR2007-001975-12-ATPIERRE FABRE MEDICAMENT - IDPF210